Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

D2m Biotherapeutics Inc.

Clinical trials sponsored by D2m Biotherapeutics Inc., explained in plain language.

Not yet finished but already full! 1

New weapon against tough cancers enters human testing

Disease control Ongoing

This is the first human study of an experimental drug called DM919 for people with advanced solid tumors that have stopped responding to standard treatments. Researchers want to find safe doses of DM919 when given alone and when combined with another cancer drug (pembrolizumab), …

Phase: PHASE1 • Sponsor: D2M Biotherapeutics Inc. • Aim: Disease control

Last updated Apr 04, 2026 07:50 UTC